NY State Senate Bill 2021-S5604

Archive: Last Bill Status - In Senate Committee Finance Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Feb 15, 2022	reported and committed to finance
Jan 05, 2022	referred to health
Mar 12, 2021	referred to health

Votes

- Feb 15, 2022 - Health Committee Vote
  S5604
  
  15
  
  Aye
  
  0
  
  Nay
  
  0
  
  Aye with Reservations
  
  0
  
  Absent
  
  0
  
  Excused
  
  0
  
  Abstained
  - - Health Committee Vote: Feb 15, 2022
      
      aye (15)
      
      Biaggi
      
      Boyle
      
      Brouk
      
      Cleare
      
      Gallivan
      
      Hoylman-Sigal
      
      Kaminsky
      
      May
      
      Oberacker
      
      Rath III
      
      Rivera
      
      Ryan
      
      Salazar
      
      Stec
      
      Thomas

co-Sponsors

View additional co-sponsors

2021-S5604 (ACTIVE) - Details

See Assembly Version of this Bill:: A6431
Current Committee:: Senate Finance
Law Section:: Public Health Law
Laws Affected:: Add §2807-aa, amd §3331, Pub Health L
Versions Introduced in 2023-2024 Legislative Session:: S1890, A2661

2021-S5604 (ACTIVE) - Summary

Establishes the "Sickle Cell Treatment Act" which designates sickle cell centers for excellence and outpatient treatment centers.

2021-S5604 (ACTIVE) - Sponsor Memo

                                
 
BILL NUMBER: S5604

SPONSOR: SANDERS
 
TITLE OF BILL:

An act to amend the public health law, in relation to establishing the
"Sickle Cell Treatment Act"; and making an appropriation therefor

 
PURPOSE:

Establishes the Sickle Cell Treatment Act

 
SUMMARY OF SPECIFIC PROVISIONS:

Section 1 of the bill would set forth that this act shall be known and
may be cited as the "Sickle Cell Treatment Act".

Section 2 amends the public health law by adding a new section 2807-aa
which mandates the Commissioner of the Department of Health to designate
Sickle cell centers for excellence and outpatient treatment centers.

Section 3 amends subdivision 8 of section 3331 of the public health law,
as added by section 7-a of part D of chapter 57 of the laws of 2018
relating to opioid exemption.

Section 4 provides the effective date.

 
JUSTIFICATION:

Sickle Cell patients experience a multitude of symptoms that can range
from mild to severe. There is little to no awareness of possible ways to
manage these symptoms, which is why centers for excellence (COE), and
outpatient treatment centers are essential.

The Centers of Excellence would serve as a hub for adults and children
alike to have access to professionals that can understand, monitor, and
provide care in the most effective way possible. The COEs would further
serve as leaders to other institutions in the treatment of SCD and would
establish the best practices that could then be used in other healthcare
facilities around the state.

Outpatient hospitals would help reduce the need of sickle cell patients
to check into the emergency room for pain, which is the traditional
response of people who are suffering an SCD pain crisis.  Patients would
have access to readily available services that are designated to help
specifically with SCD pain management and symptoms because outpatient
services would be available in areas where there is sufficient need for
the service. The reduced burden on emergency rooms, especially in times
of health crisis, can help patients and doctors alike.

Pain is a major symptom of Sickle Cell disease (SCD) and one of the
principal reasons that people with SCD go to the emergency room..  Pain
experienced by sickle cell patients manifests itself as abrupt and very
debilitating pain in any part of the body. Individuals diagnosed with
sickle cell can begin having pain crises as early as 6 months of age.
This legislation will allow certain sickle cell patients to easily gain
access to opioid therapy. Currently, sickle cell patients are restricted
in being treated with opioids. However, due to the debilitating pain

sickle cell disease patients encounter during crisis, opioid therapy
serves to reduce the pain that patients experience.

 
LEGISLATIVE HISTORY:

This is a new bill.

 
FISCAL IMPLICATIONS:

To be determined

 
EFFECTIVE DATE:
This act shall take effect immediately.

2021-S5604 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   5604
 
                        2021-2022 Regular Sessions
 
                             I N  S E N A T E
 
                              March 12, 2021
                                ___________
 
 Introduced  by  Sen. SANDERS -- read twice and ordered printed, and when
   printed to be committed to the Committee on Health
 
 AN ACT to amend the public health law, in relation to  establishing  the
   "Sickle Cell Treatment Act"; and making an appropriation therefor
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. This act shall be known and may be  cited  as  the  "Sickle
 Cell Treatment Act".
   §  2. The public health law is amended by adding a new section 2807-aa
 to read as follows:
   § 2807-AA. SICKLE CELL CENTERS FOR EXCELLENCE AND OUTPATIENT TREATMENT
 CENTERS. 1. CENTERS FOR SICKLE CELL CARE  EXCELLENCE.  THE  COMMISSIONER
 SHALL  DESIGNATE  FIVE GENERAL HOSPITALS OR HOSPICES UNDER ARTICLE FORTY
 OF THIS CHAPTER, UPON SUCCESSFUL APPLICATION, AS CENTERS FOR SICKLE CELL
 CARE EXCELLENCE. THE DESIGNATIONS SHALL BE MADE THROUGH  AN  APPLICATION
 DESIGNED  BY  THE  DEPARTMENT,  AND BASED ON SERVICE, STAFFING AND OTHER
 CRITERIA AS DEVELOPED BY THE COMMISSIONER.  THE  CENTERS  OF  EXCELLENCE
 SHALL  PROVIDE  SPECIALIZED SICKLE CELL DISEASE CARE, TREATMENT, PALLIA-
 TIVE CARE, EDUCATION AND RELATED SERVICES AND SHALL CONDUCT  SPECIALIZED
 RESEARCH INTO THE CARE, TREATMENT AND MANAGEMENT OF SICKLE CELL DISEASE.
 DESIGNATION  AS A CENTER FOR SICKLE CELL CARE EXCELLENCE SHALL NOT ENTI-
 TLE A CENTER TO ENHANCED REIMBURSEMENT, BUT MAY BE UTILIZED IN  OUTREACH
 AND  OTHER  PROMOTIONAL  ACTIVITIES.  EACH  CENTER  FOR SICKLE CELL CARE
 EXCELLENCE SHALL AFFILIATE AND COOPERATE WITH MAJOR  CENTERS  OF  HIGHER
 LEARNING,  INCLUDING  MEDICAL COLLEGES, AND LIFE SCIENCE RESEARCH INSTI-
 TUTES IN THE STATE.  THE STATE UNIVERSITY SHALL ENTER  INTO  APPROPRIATE
 LEGAL AGREEMENTS TO ENABLE THIS COOPERATION. EACH CENTER FOR SICKLE CELL
 CARE EXCELLENCE SHALL RECEIVE TWO HUNDRED THOUSAND DOLLARS PER YEAR FROM
 THE  DEPARTMENT,  FROM AMOUNTS APPROPRIATED FOR THAT PURPOSE, TO BE USED
 ON SICKLE CELL DISEASE RESEARCH.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD08525-01-1

 S. 5604                             2
 
   2. OUTPATIENT TREATMENT CENTERS. THE COMMISSIONER SHALL DESIGNATE  TEN
 HOSPITALS,  DISTRIBUTED  BASED ON SICKLE CELL PATIENT POPULATION CONCEN-
 TRATIONS, AS  SICKLE  CELL  OUTPATIENT  TREATMENT  CENTERS  WHICH  SHALL
 PROVIDE  PATIENTS  TREATMENT  FOR  SICKLE CELL DISEASE AS AN OUTPATIENT.
 EACH  SICKLE  CELL OUTPATIENT TREATMENT CENTER SHALL RECEIVE ONE HUNDRED
 THOUSAND DOLLARS PER YEAR FROM THE DEPARTMENT, FROM AMOUNTS APPROPRIATED
 FOR THAT PURPOSE, TO BE USED TO ENSURE THE PROPER MANAGEMENT AND  EQUIP-
 PING OF THE CENTERS TO CARE FOR SICKLE CELL PATIENTS.
   §  3. Subdivision 8 of section 3331 of the public health law, as added
 by section 7-a of part D of chapter 57 of the laws of 2018,  is  amended
 to read as follows:
   8.  No  opioids  shall  be prescribed to a patient initiating or being
 maintained on opioid treatment for pain which has lasted more than three
 months or past the time of normal tissue  healing,  unless  the  medical
 record contains a written treatment plan that follows generally accepted
 national  professional  or  governmental guidelines. The requirements of
 this paragraph shall not apply in the case of  patients  who  are  being
 treated  for cancer OR SICKLE CELL DISEASE that is not in remission, who
 are in hospice or other end-of-life care, or whose pain is being treated
 as part of palliative care practices.
   § 4. This act shall take effect immediately.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S5604

Sponsored By

Archive: Last Bill Status - In Senate Committee Finance Committee

Feb 15, 2022 - Health Committee Vote

Health Committee Vote: Feb 15, 2022

co-Sponsors

2021-S5604 (ACTIVE) - Details

2021-S5604 (ACTIVE) - Summary

2021-S5604 (ACTIVE) - Sponsor Memo

2021-S5604 (ACTIVE) - Bill Text download pdf

Comments

Senate Bill S5604

Share this bill

Sponsored By

Archive: Last Bill Status - In Senate Committee Finance Committee

co-Sponsors

2021-S5604 (ACTIVE) - Details

2021-S5604 (ACTIVE) - Summary

2021-S5604 (ACTIVE) - Sponsor Memo

2021-S5604 (ACTIVE) - Bill Text download pdf

Comments